{"name":"Generex Biotechnology","permalink":"generex-biotechnology","crunchbase_url":"http://www.crunchbase.com/company/generex-biotechnology","homepage_url":"http://www.generex.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@generex.com","phone_number":"(416) 364-2551","description":"","created_at":"Wed Jan 26 05:48:18 UTC 2011","updated_at":"Sat Aug 11 03:18:32 UTC 2012","overview":"<p>Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The companyâ€™s products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporationâ€™s under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada.</p>","image":{"available_sizes":[[[150,34],"assets/images/resized/0017/1695/171695v1-max-150x150.png"],[[250,57],"assets/images/resized/0017/1695/171695v1-max-250x250.png"],[[439,101],"assets/images/resized/0017/1695/171695v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President and CEO","person":{"first_name":"Mark","last_name":"Fletcher","permalink":"mark-fletcher","image":{"available_sizes":[[[150,112],"assets/images/resized/0001/9110/19110v1-max-150x150.jpg"],[[240,180],"assets/images/resized/0001/9110/19110v1-max-250x250.jpg"],[[240,180],"assets/images/resized/0001/9110/19110v1-max-450x450.jpg"]],"attribution":"<p><a href=\"http://www.wingedpig.com/bio.html\" title=\"Mark Fletcher\" rel=\"nofollow\">Mark Fletcher</a></p>"}}},{"is_past":true,"title":"CFO, COO","person":{"first_name":"Rose","last_name":"C. Perri","permalink":"rose-c-perri","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$9.35M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/01/24/daily24-Generex-lands-3M-expands-breast-cancer-vaccine-study.html","source_description":"Generex lands $3M, expands breast cancer vaccine study","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":25,"investments":[]},{"round_code":"debt_round","source_url":"http://www.generex.com/news.php/news/642168","source_description":"Generex Secures Commitments for $3.6M Capital Raise - Wednesday, January 25, 2012","raised_amount":3600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":25,"investments":[]},{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/01/30/daily70-Generex-gets-2M-investment-boost.html","source_description":"Generex gets $2M investment boost","raised_amount":2000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":1,"investments":[]},{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/08/06/daily56-Generex-gets-750K-capital-investment.html","source_description":"Generex gets $750K capital investment","raised_amount":750000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":10,"investments":[]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"33 Harbour Square","address2":"Suite 202","zip_code":"M5J 2G2","city":"Toronto, Ontario","state_code":null,"country_code":"CAN","latitude":null,"longitude":null}],"milestones":[{"description":"announced a series of operational changes intended help grow the Worcester drug delivery firm","stoned_year":2011,"stoned_month":3,"stoned_day":30,"source_url":"http://www.masshightech.com/stories/2011/03/28/daily38-Generex-to-spin-out-Antigen-Express-names-new-exec-team.html","source_text":null,"source_description":"Generex to spin out Antigen Express, names new exec team","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Generex Biotechnology","permalink":"generex-biotechnology"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}